Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335
Q2 FY25 results · Jul–Sep 2024
Zydus Wellness reported revenue from operations of ₹492.90 crore (up 12.0% from Q2 FY24) and net profit of ₹20.90 crore (up 254.2% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 492.90 | 439.90 | +12.0% | 841.00 | −41.4% |
| Other income | 4.00 | 4.10 | −2.4% | 5.00 | −20.0% |
| Total income | 496.90 | 444.00 | +11.9% | 846.00 | −41.3% |
| Profit before tax | 23.70 | 8.60 | +175.6% | 151.60 | −84.4% |
| Net profit for the period | 20.90 | 5.90 | +254.2% | 147.70 | −85.8% |
| EPS, basic (₹) | 3.28 | 0.93 | +252.7% | 23.21 | −85.9% |
| Net margin (%) | 4.2 | 1.3 | 17.6 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 63.30 | 57.80 | +9.5% | 63.40 | −0.2% |
| Other income | 4.10 | 4.60 | −10.9% | 4.80 | −14.6% |
| Total income | 67.40 | 62.40 | +8.0% | 68.20 | −1.2% |
| Profit before tax | 10.50 | 10.40 | +1.0% | 8.40 | +25.0% |
| Net profit for the period | 8.00 | 7.80 | +2.6% | 6.20 | +29.0% |
| EPS, basic (₹) | 1.26 | 1.23 | +2.4% | 0.97 | +29.9% |
| Net margin (%) | 12.6 | 13.5 | 9.8 |
Consolidated
- Filed with BSE
- 11 Nov 2024, 15:39 IST
- Board meeting
- 11 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2024, 15:39 IST
- Board meeting
- 11 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE